Nanomedicine-Nanotechnology Biology and Medicine

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

Nanomedicine-Nanotechnology Biology and Medicine

NANOMED-NANOTECHNOL

ISSN / eISSN

1549-9634 / 1549-9642

目标和范围

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.

Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.

研究方向

医学：研究与实验

纳米科技

CiteScore

11.90

查看趋势图

CiteScore 学科排名

类别	分区	排名
Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science	Q1	#10/171
Pharmacology, Toxicology and Pharmaceutics - Medicine (miscellaneous)	Q1	#20/309
Pharmacology, Toxicology and Pharmaceutics - Biomedical Engineering	Q1	#24/277
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine	Q1	#21/171
Pharmacology, Toxicology and Pharmaceutics - General Materials Science	Q1	#56/453
Pharmacology, Toxicology and Pharmaceutics - Bioengineering	Q1	#20/153

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE	Q2
NANOSCIENCE & NANOTECHNOLOGY - SCIE	Q2

H-index

106

出版国家或地区

NETHERLANDS

出版商

Elsevier Inc.

出版周期

Quarterly

出版年份

2005

年文章数

157

Open Access

通讯方式

ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

同领域相关热门期刊
近期发表文章

Long term exercise-derived exosomal LncRNA CRNDE mitigates myocardial infarction injury through miR-489-3p/Nrf2 signaling axis: (2023) Wujun Chen, Qiaoyi Ye, Yi Dong

Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis: (2023) Daniela Rubanová, Svitlana Skoroplyas, Alena Libánská, Eva Randárová, Josef Bryja, Michaela Chorvátová, Tomáš Etrych, Lukáš Kubala

Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles: (2023) Thanpisit Lomphithak, Apiwit Sae-Fung, Simone Sprio, Anna Tampieri, Siriporn Jitkaew, Bengt Fadeel

Coating influence on inner shell water exchange: An underinvestigated major contributor to SPIONs relaxation properties: (2023) Yusong Peng, Yunlong Li, Li Li, Manman Xie, Yiqing Wang, Christopher J. Butch

Liposomes - Human phagocytes interplay in whole blood: effect of liposome design: (2023) Miriam Giambelluca, Elena Markova, Claire Louet, Bjørg Steinkjer, Rune Sundset, Nataša Škalko-Basnet, Sjoerd Hak

Delivery of gene editing therapeutics: (2023) Bhavesh D. Kevadiya, Farhana Islam, Pallavi Deol, Lubaba A. Zaman, Dina A. Mosselhy, Md Ashaduzzaman, Neha Bajwa, Nanda Kishore Routhu, Preet Amol Sin...

Fabrication of blended nanofibrous cardiac patch transplanted with TGF-β3 and human umbilical cord MSCs-derived exosomes for potential cardiac regeneration after acute myocardial infarction: (2023) Ping Ping, Shasha Guan, Chaoxue Ning, Ting Yang, Yali Zhao, Pei Zhang, Zhitao Gao, Shihui Fu

Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells: (2023) Valeria Unida, Eleonora Mangano, Tania Camboni, Clarissa Consolandi, Alessandro Desideri, Marco Severgnini, Ingrid Cifola, Silvia Biocca

Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer: (2023) Weiwei Zhang, Ye Wang, Jinzhi He, Yinggang Xu, Rui Chen, Xinyu Wan, Wenjie Shi, Xiaofeng Huang, Lu Xu, Jue Wang, Xiaoming Zha

State-of-the-art and future perspectives in infertility diagnosis: Conventional versus nanotechnology-based assays: (2023) Bianca-Astrid Andone, Iuliana M. Handrea-Dragan, Ioan Botiz, Sanda Boca

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

Submitted at the end of September, it took a month and a half to wait for two reviewers willing to review. The received feedback seemed like an automated email, with mainly official statements at the beginning, stating that they couldn't accept the current version. However, if the revised version based on the reviewers' comments is submitted again, they would reconsider acceptance. The email also included minor suggestions from the two reviewers. No additional experiments were requested. After two weeks of revision, it was resubmitted and accepted the next morning.

2022-12-23

Received the review results four months after submission. The first time it was sent back for revisions, it took a month for the editor to put it "under review." It took them three weeks to notify me of the completed required review. Now, it has been a month since the second revision was submitted, and it is still "with editor." I sent an email to urge them, and received a sincere reply from someone. However, a week has passed and it is still "with editor." The entire process has already been eight months, and I still can't see any hope of acceptance.

2023-02-23

查看所有评论

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now